Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	GenMark Diagnostics	Luminex	Cardiovascular Systems	Alphatec	MiMedx Group
Symbol	NASDAQ:GNMK	NASDAQ:LMNX	NASDAQ:CSII	NASDAQ:ATEC	NASDAQ:MDXG
Price Information
Current Price	$23.99	$36.80	$38.22	$17.23	$12.30
52 Week Range	Hold	Hold	Buy	Buy	Buy
MarketRank™
Overall Score	1.5	1.5	1.5	0.8	1.7
Analysis Score	2.0	1.0	2.5	1.5	3.5
Community Score	3.1	2.0	2.6	2.0	5.0
Dividend Score	0.0	0.8	0.0	0.0	0.0
Ownership Score	1.7	1.7	1.7	0.0	0.0
Earnings & Valuation Score	0.6	1.9	0.6	0.6	0.0
Analyst Ratings
Consensus Recommendation	Hold	Hold	Buy	Buy	Buy
Consensus Price Target	$22.01	$37.00	$47.57	$15.43	$20.00
% Upside from Price Target	-8.24% downside	0.54% upside	24.47% upside	-10.46% downside	62.60% upside
Trade Information
Market Cap	$1.75 billion	$1.74 billion	$1.54 billion	$1.64 billion	$1.37 billion
Beta	3.02	0.61	1.19	1.53	1.71
Average Volume	2,711,742	991,164	212,548	696,709	563,470
Sales & Book Value
Annual Revenue	$88.02 million	$334.64 million	$236.54 million	$113.43 million	$299.26 million
Price / Sales	19.92	5.20	6.49	14.45	4.57
Cashflow	N/A	$0.59 per share	N/A	N/A	N/A
Price / Cash	N/A	62.90	N/A	N/A	N/A
Book Value	$0.21 per share	$10.32 per share	$7.62 per share	$0.71 per share	$0.31 per share
Price / Book	114.24	3.57	5.02	24.27	39.68
Profitability
Net Income	$-47,350,000.00	$-3,840,000.00	$-27,240,000.00	$-57,000,000.00	$-25,580,000.00
EPS	($0.82)	($0.21)	($0.79)	($1.09)	N/A
Trailing P/E Ratio	N/A	94.36	N/A	N/A	N/A
Forward P/E Ratio	N/A	40.89	N/A	N/A	∞
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	-16.95%	4.60%	-10.12%	-51.95%	-37.28%
Return on Equity (ROE)	-39.36%	3.75%	-11.43%	-266.45%	-404.08%
Return on Assets (ROA)	-13.02%	2.73%	-8.36%	-40.80%	-58.81%
Dividend
Annual Payout	N/A	$0.40	N/A	N/A	N/A
Dividend Yield	N/A	1.09%	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	54.17%	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	1 Years	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.75%	0.39%	0.08%	8.17%	3.70%
Current Ratio	4.33%	6.45%	6.25%	1.80%	2.99%
Quick Ratio	3.84%	5.01%	5.61%	0.92%	2.80%
Ownership Information
Institutional Ownership Percentage	96.94%	88.09%	89.70%	31.76%	4.03%
Insider Ownership Percentage	3.25%	9.40%	3.00%	28.18%	19.80%
Miscellaneous
Employees	618	1,325	779	296	735
Shares Outstanding	73.09 million	47.30 million	40.19 million	95.15 million	111.26 million
Next Earnings Date	5/3/2021 (Estimated)	5/3/2021 (Estimated)	5/6/2021 (Confirmed)	5/10/2021 (Estimated)	7/5/2021 (Estimated)
Optionable	Optionable	Optionable	Optionable	Not Optionable	Optionable

Source	Headline
	MiMedx Group (NASDAQ:MDXG) Reaches New 52-Week High at $12.80 americanbankingnews.com - April 12 at 6:36 PM
	Is MiMedx Group, Inc. (NASDAQ:MDXG) Popular Amongst Insiders? finance.yahoo.com - April 12 at 1:58 PM
	MiMedx Group (NASDAQ:MDXG) Shares Gap Down to $12.18 americanbankingnews.com - April 7 at 11:00 AM
	MiMedx Group (NASDAQ:MDXG) Trading Up 5.7% americanbankingnews.com - April 6 at 2:30 PM
	MiMedx Group (NASDAQ:MDXG) Sets New 12-Month High at $11.44 americanbankingnews.com - April 5 at 1:28 PM
	MiMedx Group, Inc. (NASDAQ:MDXG) Sees Large Decline in Short Interest americanbankingnews.com - April 1 at 5:26 AM
	MiMedx Group (NASDAQ:MDXG) Shares Up 8.1% americanbankingnews.com - March 30 at 2:55 PM
	MiMedx Awarded Amniotic Tissue Supplier Agreement with Premier® Inc.’s SURPASS™ Purchasing Program finance.yahoo.com - March 30 at 8:46 AM
	MiMedx Group (NASDAQ:MDXG) Shares Gap Down to $9.80 americanbankingnews.com - March 29 at 11:48 AM
	MiMedx Group (NASDAQ:MDXG) Trading Down 6% americanbankingnews.com - March 25 at 11:37 AM
	MiMedx Group (NASDAQ:MDXG) Coverage Initiated by Analysts at HC Wainwright americanbankingnews.com - March 25 at 9:00 AM
	Contrasting MiMedx Group (NASDAQ:MDXG) and Haemonetics (NYSE:HAE) americanbankingnews.com - March 23 at 10:44 PM
	MiMedx Group (NASDAQ:MDXG) Stock Price Up 5.1% americanbankingnews.com - March 22 at 11:47 AM
	MDXG Stock Price Increased 15.21%: Why It Happened pulse2.com - March 22 at 9:20 AM
	MiMedx Group, Inc. (MDXG) CEO Tim Wright on Q4 2020 Results - Earnings Call Transcript seekingalpha.com - March 11 at 4:47 AM
	MiMedx Group EPS misses by $0.12, beats on revenue seekingalpha.com - March 10 at 3:02 PM
	MiMedx Group, Inc. to Host Earnings Call finance.yahoo.com - March 9 at 8:41 AM
	MiMedx: Q4 Earnings Snapshot \| Raleigh News & Observer newsobserver.com - March 8 at 7:17 PM
	MiMedx: Q4 Earnings Snapshot finance.yahoo.com - March 8 at 7:17 PM
	MiMedx to Participate at Upcoming Investor Conferences finance.yahoo.com - March 3 at 12:24 PM
	MiMedx to Host Fourth Quarter and Full Year 2020 Operating and Financial Results Conference Call on March 9 finance.yahoo.com - March 2 at 9:07 AM
	Should MiMedx Group (NASDAQ:MDXG) Be Disappointed With Their 41% Profit? finance.yahoo.com - February 25 at 11:14 AM
	CEO Who Blamed His Cancer on Short Sellers Set for Sentencing finance.yahoo.com - February 23 at 12:56 PM
	MDXG: From Womb to Wound finance.yahoo.com - February 18 at 2:45 PM
	Reminder: MiMedx to Present at the 39th Annual J.P. Morgan Healthcare Conference finance.yahoo.com - January 6 at 8:12 AM

Date	Company	Brokerage	Action
3/23/2021	GenMark Diagnostics	Cowen	Reiterated Rating
3/23/2021	GenMark Diagnostics	BTIG Research	Reiterated Rating
3/22/2021	GenMark Diagnostics	Needham & Company LLC	Reiterated Rating
3/22/2021	GenMark Diagnostics	Canaccord Genuity	Reiterated Rating
3/15/2021	GenMark Diagnostics	William Blair	Downgrade
2/11/2020	GenMark Diagnostics	Raymond James	Downgrade
12/11/2019	GenMark Diagnostics	JPMorgan Chase & Co.	Downgrade
4/13/2021	Luminex	Piper Sandler	Downgrade
11/6/2018	Luminex	Citigroup	Lower Price Target
8/7/2018	Luminex	Jefferies Financial Group	Reiterated Rating
5/7/2018	Luminex	Deutsche Bank Aktiengesellschaft	Upgrade
3/17/2021	Cardiovascular Systems	Oppenheimer	Reiterated Rating
2/15/2021	Cardiovascular Systems	Aegis	Reiterated Rating
12/16/2020	Cardiovascular Systems	Northland Securities	Boost Price Target
12/14/2020	Cardiovascular Systems	SVB Leerink	Boost Price Target
7/17/2020	Cardiovascular Systems	Barclays	Initiated Coverage
5/6/2020	Cardiovascular Systems	Lake Street Capital	Lower Price Target
10/17/2019	Cardiovascular Systems	Guggenheim	Initiated Coverage
7/16/2019	Cardiovascular Systems	Stifel Nicolaus	Downgrade
4/11/2019	Cardiovascular Systems	Bank of America	Downgrade
3/11/2021	Alphatec	HC Wainwright	Boost Price Target
10/31/2019	Alphatec	Piper Jaffray Companies	Boost Price Target

(Data available from 4/16/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources